Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
0.7100
+0.0006 (0.08%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Myomo Revenue
In the year 2025, Myomo had annual revenue of $40.93M with 25.73% growth. Myomo had revenue of $11.35M in the quarter ending December 31, 2025, a decrease of -5.93%.
Revenue (ttm)
$40.93M
Revenue Growth
+25.73%
P/S Ratio
0.67
Revenue / Employee
$209,887
Employees
195
Market Cap
27.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.93M | 8.38M | 25.73% |
| Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
| Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
| Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
| Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
| Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
| Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
| Dec 31, 2018 | 2.44M | 885.24K | 56.79% |
| Dec 31, 2017 | 1.56M | 455.59K | 41.29% |
| Dec 31, 2016 | 1.10M | 413.61K | 59.97% |
| Dec 31, 2015 | 689.67K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 116.67M |
| TELA Bio | 77.06M |
| IRIDEX | 50.65M |
| Cytosorbents | 36.98M |
| NeuroOne Medical Technologies | 11.72M |
| Pulsenmore | 2.76M |
| VolitionRx | 1.47M |
| Envoy Medical | 208.00K |
MYO News
- 14 days ago - Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Business Wire
- 14 days ago - Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
- 21 days ago - Myomo to Report Fourth Quarter 2025 Financial Results on March 9 - Business Wire
- 4 months ago - Myomo Reports Third Quarter 2025 Financial and Operating Results - Business Wire
- 5 months ago - Myomo to Report Third Quarter 2025 Financial Results on November 10 - Business Wire
- 7 months ago - Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 8 months ago - Myomo Reports Second Quarter 2025 Financial and Operating Results - Business Wire
- 8 months ago - Myomo to Report Second Quarter 2025 Financial Results on August 11 - Business Wire